Viewing Study NCT03009461


Ignite Creation Date: 2025-12-24 @ 12:43 PM
Ignite Modification Date: 2025-12-27 @ 4:08 PM
Study NCT ID: NCT03009461
Status: COMPLETED
Last Update Posted: 2024-12-04
First Post: 2017-01-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis
Sponsor: Peking University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module